Yonghe Medical (02279) Schedules 31 Mar 2026 Board Meeting to Review FY 2025 Results and Dividend Proposal

Bulletin Express

03/19

Yonghe Medical Group Co., Ltd. (02279) has announced that its Board of Directors will convene on 31 March 2026.

The meeting will focus on:

1. Reviewing and approving the consolidated financial results for the fiscal year ended 31 December 2025.

2. Considering the recommendation of a final dividend for the period, subject to Board approval.

3. Addressing any additional corporate matters raised during the session.

Board composition at the time of the announcement comprises three executive directors—ZHANG Yu, ZHANG Hui and HAN Zhimei; one non-executive director—GENG Jiaqi; and three independent non-executive directors—LIANG Jihong, CHAN Peng Kuan and LI Xiaopei.

The notice was signed by Chairman ZHANG Yu and dated 19 March 2026 in Hong Kong.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1157011490"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1157011490\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1157011490?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-19 16:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1157011490","market":"hk","top_or_hot":-1,"title":"Yonghe Medical (02279) Schedules 31 Mar 2026 Board Meeting to Review FY 2025 Results and Dividend Proposal","media":"Bulletin Express","content":"<p>Yonghe Medical Group Co., Ltd. (02279) has announced that its Board of Directors will convene on 31 March 2026.</p>\n<p>The meeting will focus on:</p>\n<p>1. Reviewing and approving the consolidated financial results for the fiscal year ended 31 December 2025.</p>\n<p>2. Considering the recommendation of a final dividend for the period, subject to Board approval.</p>\n<p>3. Addressing any additional corporate matters raised during the session.</p>\n<p>Board composition at the time of the announcement comprises three executive directors—ZHANG Yu, ZHANG Hui and HAN Zhimei; one non-executive director—GENG Jiaqi; and three independent non-executive directors—LIANG Jihong, CHAN Peng Kuan and LI Xiaopei.</p>\n<p>The notice was signed by Chairman ZHANG Yu and dated 19 March 2026 in Hong Kong.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Yonghe Medical (02279) Schedules 31 Mar 2026 Board Meeting to Review FY 2025 Results and Dividend Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nYonghe Medical (02279) Schedules 31 Mar 2026 Board Meeting to Review FY 2025 Results and Dividend Proposal\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-03-19 16:44</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Yonghe Medical Group Co., Ltd. (02279) has announced that its Board of Directors will convene on 31 March 2026.</p>\n<p>The meeting will focus on:</p>\n<p>1. Reviewing and approving the consolidated financial results for the fiscal year ended 31 December 2025.</p>\n<p>2. Considering the recommendation of a final dividend for the period, subject to Board approval.</p>\n<p>3. Addressing any additional corporate matters raised during the session.</p>\n<p>Board composition at the time of the announcement comprises three executive directors—ZHANG Yu, ZHANG Hui and HAN Zhimei; one non-executive director—GENG Jiaqi; and three independent non-executive directors—LIANG Jihong, CHAN Peng Kuan and LI Xiaopei.</p>\n<p>The notice was signed by Chairman ZHANG Yu and dated 19 March 2026 in Hong Kong.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02279","symbol_name":"雍禾醫療","start_time":0,"source_url":"","article_id":"1157011490","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1157011490","pubTimestamp":1773909860,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Yonghe Medical Group Co., Ltd. (02279) has announced that its Board of Directors will convene on 31 March 2026. The meeting will focus on: 1. Reviewing and approving the consolidated financial...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02279":"雍禾医疗"},"translate_title":"雍禾医疗(02279)安排2026年3月31日董事会会议审阅2025财年业绩及股息建议","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02279":1},"content_text":"Yonghe Medical Group Co., Ltd. (02279) has announced that its Board of Directors will convene on 31 March 2026.\nThe meeting will focus on:\n1. Reviewing and approving the consolidated financial results for the fiscal year ended 31 December 2025.\n2. Considering the recommendation of a final dividend for the period, subject to Board approval.\n3. Addressing any additional corporate matters raised during the session.\nBoard composition at the time of the announcement comprises three executive directors—ZHANG Yu, ZHANG Hui and HAN Zhimei; one non-executive director—GENG Jiaqi; and three independent non-executive directors—LIANG Jihong, CHAN Peng Kuan and LI Xiaopei.\nThe notice was signed by Chairman ZHANG Yu and dated 19 March 2026 in Hong Kong.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}